Vatalanib: the clinical development of a tyrosine kinase inhibitor of angiogenesis in solid tumours.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F4C01112.svg?ark=w1%2F20260515%2FF4C01112)](https://nobleid.org/work/w1/20260515/F4C01112)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors